EP Patent

EP4574168A1 — Prime-boost immunization against influenza

Assigned to Institut Fuer Virologie und Immunologie Ivi · Expires 2025-06-25 · 1y expired

What this patent protects

The invention relates to compositions and methods for immunisation against influenza virus.

USPTO Abstract

The invention relates to compositions and methods for immunisation against influenza virus.

Drugs covered by this patent

Leustatin (CLADRIBINE)

Patent Metadata

Patent number: EP4574168A1
Jurisdiction: EP
Classification: —
Expires: 2025-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Institut Fuer Virologie und Immunologie Ivi
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.